Both Short- and Long-term Outcome Differences According to Patient Frailty
Sponsor
Kochi University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05257226
Collaborator
(none)
1,000
1
144
6.9
Study Details
Study Description
Brief Summary
The evaluation for cancer treatment successful has been used by overall survival rate and/or postoperative complications, especially surgical area. Now postoperative QOL has been more importantly required. Therefore this study was conduced to investigate the association between postoperative outcomes and patients frailty.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
1000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Both Short- and Long-term Outcome Differences According to Patient Frailty
Actual Study Start Date
:
Jan 1, 2019
Anticipated Primary Completion Date
:
Jan 31, 2025
Anticipated Study Completion Date
:
Dec 31, 2030
Outcome Measures
Primary Outcome Measures
- postoperative short-term outcomes [up to 24 weeks]
postoperative complications
Secondary Outcome Measures
- postoperative long-term outcomes [5 year]
survival rate
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 90 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
- surgical patients
Exclusion Criteria:
- a body weight loss of >10% during the 6 months before surgery; the presence of distant metastases; or seriously impaired function of vital organs because of respiratory, renal, or heart disease
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Takehiro Okabayashi | Kochi | Japan | 781-8555 |
Sponsors and Collaborators
- Kochi University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Takehiro Okabayashi,
Department of Gastroenterological Surgery,
Kochi University
ClinicalTrials.gov Identifier:
NCT05257226
Other Study ID Numbers:
- Bos study
First Posted:
Feb 25, 2022
Last Update Posted:
Feb 25, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: